COMP <GO>
FCN vs PG // EV/EBITDA & P/E VALUATION
FTI Consulting Inc. (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: FCN 4
— PG 9
▲ EV/EBITDA & P/E VALUATION LEADER: FCN
LAST: $191.77 (+4.88%) • MKT CAP: $4.98B
valuation
11.6x
LAST: $163.56 (+1.23%) • MKT CAP: $374.48B
valuation
16.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FCN VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FCN | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.10% | 51.20% | -19.10 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.80% | 25.40% | -8.60 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 11.6x | 16.2x | -4.60 | FCN | /valuation <GO> |
| Free Cash Flow Yield | 1.87% | 3.77% | -1.90 | PG | /fcf-yield <GO> |
| Operating Margin | 10.30% | 24.30% | -14.00 | PG | /operating-margins <GO> |
| Net Profit Margin | 7.10% | 19.00% | -11.90 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 2.40% | 0.30% | +2.10 | FCN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.10 | 5.59 | -1.49 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 79.1 | 62.0 | +17.10 | FCN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.87 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.2x | 21.7x | -4.50 | FCN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.98B | $374.48B | -$369.50B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FCN REV | PG REV | FCN GROSS % | PG GROSS % | FCN FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.79B | $84.28B | 32.1% | 51.2% | $93.6M | $14.04B |
| FY 2024 | $3.70B | $84.04B | 32.0% | 51.4% | $359.7M | $16.52B |
| FY 2023 | $3.49B | $82.01B | — | — | $67.4M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FCN // BETA 0.87
PG // BETA 0.87